EU supplementary protection certificates: beyond the CJEU
This article was originally published in SRA
Executive Summary
Katie McConnell argues that recent decisions by the English courts on SPCs prove that last year's CJEU judgments fail to provide certainty for the pharmaceutical industry and provide a basis for yet more litigation.